M. Ochs (Hannover, Germany), J. Chorostowska-Wynimko (Warsaw, Poland)
Analysis of the airway transcriptome in two rat strains of differing airway responsiveness
T. Jo, K. Tsuchiya, P. A. Risse, J. Martin (Montreal, Canada)
|  |
The effect of nicotine on COX-dependent airway relaxation and inflammatory mediator expression
Y. Xu, Y. Zhang, L. O. Cardell (Stockholm, Sweden)
| |
Molecular changes in peripheral blood of asthmatic individuals undergoing allergen inhalation challenge
S. Tebbutt, L. P. Boulet, M. FitzGerald, G. Gauvreau, S. Kam, C. Kanagaratham, D. Radzioch, G. Wojewodka, P. O‘Byrne (Vancouver, Sainte-Foy, Hamilton, Montreal, Canada)
|  |
Protective effect of intronic polymorphism rs324011 of STAT6 gene on asthma severity
V. Mineev, M. Nyoma, L. Sorokina, M. Dubina, E. Yanchina, V. Trofimov (Russian Federation)
| |
The evaluation of pharmacogenetic relationship of beta 2-adrenoceptors and response to salmeterol
F. Fahimi, P. Adimi, S. A. Naji, N. Naderi, S. Morovvati, F. Soleymani, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
V. Bessa, K. Darwiche, B. Bödeker, J. I. Baumbach, U. Sommerwerck, O. Anhenn, L. Freitag (Essen, Germany)
| |
Simvastatin attenuates cigarette-smoke- induced emphysema and promotion of alveolar epithelial cell proliferation in rats
S. Xia, J. Kang, D. Hua, S. Wang, B. Pang (Shenyang, China)
| |
Genetic analysis of the mouse bradypneic (bd) mutation
C. Poirier, C. Dimitropoulou, A. Verin (Augusta, United States Of America)
| |
Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
E. Neofytou, N. Soulitzis, I. Bouloukaki, A. Solakis, E. Mavroudi, S. Schiza, N. Siafakas, E. Tzortzaki (Heraklion, Greece)
| |
Association of C3435T polymorphism of MDR1 gene and T1808A polymorphism of NR3C1 gene with bronchial obstruction in severe asthmatics and COPD patients
M. Simakova, Z. Mironova, V. Trofimov, E. Iantchina, M. Dubina, V. Belash (St. Petersburg, Russian Federation)
| |
Human EGF and ERBB receptors family mRNA expression in smokers with and without COPD: Preliminary results
A. Anagnostis, E. Neofytou, N. Soulitzis, A. Solakis, V. Amargianitakis, N. Siafakas, E. Tzortzaki (Heraklion, Greece)
| |
The role of matrix metalloproteinase-9 in the formation of chronic obstructive pulmonary disease associated with coronary heart disease
V. Nevzorova, T. Tilik, S. Vakhrusheva, J. Maistrovska, E. Gilifanov, O. Golotina (Vladivostok, Russian Federation)
| |
The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia
M. Ostrovskyy, O. Varunkiv, I. Savelikhina (Ivano-Frankivsk, Ukraine)
| |
Experimental discovery of small regulatory RNAs in M. tuberculosis: A genome-wide analysis
P. Miotto, A. Alessandro, P. Danilo, C. Di Serio, D. Cirillo (Milan, Italy)
| |
Analysis of the 3‘ untranslated regions (UTR) of hSP-A1 variants: Impact of sequence elements on differential expression, secondary structure and microRNA binding
P. Silveyra, G. Wang, J. Floros (Hershey, United States Of America)
| |
Study of gene expression control elements of the human SP-A genes: Role of the 5‘UTR exon B
P. Silveyra, B. Simmons, M. Raval, G. Wang, J. Floros (Hershey, United States Of America)
| |
Analysis of the human SP-A 5‘UTR exon B: Identification of regulatory regions
P. Silveyra, B. Simmons, M. Raval, S. DiAngelo, G. Wang, J. Floros (Hershey, United States Of America)
| |
Novel assessment of alpha galactosidase A enzyme (GLA) activity in induced sputum (IS) and blood in patients with Anderson Fabry disease (AFD)
N. Shafi, D. Hughes, A. Mehta, R. Baker, M. Lipman (London, United Kingdom)
| |